[ad_1]
Jakarta, CNBC Indonesia – During the trading weekend on Friday (12/4/2020), the Jakarta Composite Index (IHSG) corrected 0.21% to the level of 5,810.48. The transaction value has reached IDR 13.06 trillion and the overseas net sales in all markets are IDR 84.5 billion.
The increasing daily positive cases of the Corona virus in Indonesia turned into negative sentiment for stock trading late last week. But today the positive sentiment came after it was confirmed that the Covid-19 vaccine had reached Indonesia last night up to 1.2 million doses of Sinovac.
Furthermore, the negative sentiment also came from the giant pharmaceutical company Pfizer, which announced that it could only ship half of its total Covid-19 vaccine target this year.
Pfizer said the vaccine developed in collaboration with BioNTech lacked raw materials, where currently available raw materials did not meet standards, the Wall Street Journal reported.
The giant pharmaceutical company expects to deliver just 50 million doses this year and removes hopes of a rapid economic recovery after the corona virus, which is certainly necessary to jumpstart the economy.
Earlier this week, on Monday (7/12/2020), several brokers selected the following stocks:
1. Samuel Sekuritas Indonesia – There will be correction before the rally
JCI continued bullish sentiment after bouncing off 5,600 levels. Post-bounce doji candles give an indication of the possibility of a temporary correction before the rally continues.
Preferred shares:
2. Reliance Sekuritas Indonesia – Index Can Strengthen Limited
Technically, JCI confirmed a consolidated movement pattern weakening again to test the MA5 resistance. The stochastic indicator is overbought and the momentum of the RSI indicator is moving quite high. Therefore, it is estimated that JCI has the potential to move to limited strengthening.
Preferred shares:
